Teleflex Incorporated Cost of Revenue | TFX

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Teleflex Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
872 M	662 M	672 M	1.26 B	1.26 B	1.21 B	1.19 B	1.15 B	975 M	872 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.26 B	662 M	1.01 B

Quarterly Cost of Revenue Teleflex Incorporated

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2
239 M	241 M	461 M	350 M	311 M	334 M	333 M	322 M	330 M	335 M	320 M	-	313 M	316 M	295 M	-	312 M	316 M	289 M	-	299 M	289 M	297 M	-	293 M	300 M	290 M	-	267 M	265 M	256 M	-	239 M	238 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
461 M	238 M	302 M

Cost of Revenue of other stocks in the Medical instruments industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	107 K	-	-	$ 810 M	USA
Alcon ALC	4.59 B	$ 67.76	0.03 %	$ 33.4 B	Schweiz
AngioDynamics ANGO	145 M	$ 15.68	1.1 %	$ 651 M	USA
AtriCure ATRC	134 M	$ 56.22	0.77 %	$ 2.68 B	USA
Baxter International BAX	7.86 B	$ 23.71	0.25 %	$ 12.2 B	USA
Becton, Dickinson and Company BDX	11.9 B	$ 185.92	1.65 %	$ 53.5 B	USA
The Cooper Companies COO	1.41 B	$ 53.27	0.58 %	$ 10.6 B	USA
BioLife Solutions BLFS	34.1 M	$ 36.39	2.71 %	$ 1.74 B	USA
electroCore ECOR	4.24 M	$ 10.05	2.97 %	$ 85.3 K	USA
Glaukos Corporation GKOS	112 M	$ 171.68	0.34 %	$ 9.82 B	USA
Haemonetics Corporation HAE	546 M	$ 106.2	0.03 %	$ 5.01 B	USA
Harvard Bioscience HBIO	36.6 M	$ 7.98	0.75 %	$ 354 M	USA
ICU Medical ICUI	1.41 B	$ 155.88	0.72 %	$ 3.84 B	USA
InfuSystem Holdings INFU	63.1 M	$ 12.26	0.08 %	$ 253 M	USA
iRhythm Technologies IRTC	220 M	$ 111.88	2.95 %	$ 3.58 B	USA
Intuitive Surgical ISRG	3.42 B	$ 377.16	0.01 %	$ 135 B	USA
Repro Med Systems KRMD	15.5 M	$ 3.16	0.64 %	$ 146 M	USA
LeMaitre Vascular LMAT	71.1 M	$ 80.24	0.22 %	$ 1.82 B	USA
Microbot Medical MBOT	2.07 M	$ 1.44	0.34 %	$ 65.9 M	Israel
Milestone Scientific MLSS	2.57 M	$ 0.4	1.42 %	$ 32.8 M	USA
Merit Medical Systems MMSI	778 M	$ 86.18	0.76 %	$ 5.1 B	USA
Nephros NEPH	7.16 M	$ 4.29	0.45 %	$ 45.5 M	USA
Envista Holdings Corporation NVST	1.23 B	$ 24.73	0.94 %	$ 4.15 B	USA
Pro-Dex PDEX	53.2 M	$ 66.91	0.53 %	$ 216 B	USA
Pulse Biosciences PLSE	539 K	$ 55.2	1.83 %	$ 3.72 B	USA
ResMed RMD	2.2 B	$ 229.44	2.92 %	$ 33.4 B	USA
Retractable Technologies RVP	38.2 M	$ 0.68	0.03 %	$ 20.4 M	USA
STAAR Surgical Company STAA	57 M	$ 22.45	1.81 %	$ 1.11 B	USA
STERIS plc STE	3.31 B	$ 210.28	1.36 %	$ 20.6 B	USA
OraSure Technologies OSUR	66.8 M	$ 3.46	2.67 %	$ 254 M	USA
Utah Medical Products UTMD	16.5 M	$ 74.63	5.6 %	$ 242 M	USA
Repligen Corporation RGEN	352 M	$ 174.73	4.01 %	$ 9.83 M	USA
West Pharmaceutical Services WST	1.97 B	$ 365.0	2.76 %	$ 26.4 B	USA
DENTSPLY SIRONA XRAY	1.84 B	$ 9.83	0.62 %	$ 1.96 B	USA
Stereotaxis STXS	15.3 M	$ 1.32	3.1 %	$ 120 M	USA
NeuroMetrix NURO	1.35 M	-	5.05 %	$ 9.02 M	USA
Ekso Bionics Holdings EKSO	88.7 M	-	-	$ 28.6 M	USA
Isoray ISR	2.74 M	-	0.03 %	$ 108 M	USA
Masimo Corporation MASI	1.09 B	-	-	$ 9.59 B	USA
Predictive Oncology POAI	72.6 K	-	-	$ 31.1 M	USA